ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-73 Cr | ₹-59 Cr | ₹-26 Cr | ₹-49 Cr | ₹-26 Cr |
What is the latest Cash Flow from Financing Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-73 Cr |
| Mar2024 | ₹-59 Cr |
| Mar2023 | ₹-26 Cr |
| Mar2022 | ₹-49 Cr |
| Mar2021 | ₹-26 Cr |
How is Cash Flow from Financing Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-73 Cr | Negative | |
| Mar2024 | ₹-59 Cr | Negative | |
| Mar2023 | ₹-26 Cr | Negative | |
| Mar2022 | ₹-49 Cr | Negative | |
| Mar2021 | ₹-26 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹4,080.7 Cr | -2.9% | 6.5% | 27.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2.9% |
6.5% |
27.7% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses